DCAT Announces New Board of Directors

  • Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT).Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT).

Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to serve as officers of DCAT are: Stephan Kutzer, president and CEO of Alcami, as first vice president; Sean Diver, director, business development, early intermediates at Lonza, as second vice president; and Kerri McCullough Wood, senior vice president and head of commercial, TAPI, Teva. All will serve one-year terms, effective Nov. 1, 2018.

In addition, the following individuals have been newly elected or will continue to serve one-year terms on the board.

Directors:

Elodie Cramer, associate director, Global Procurement, Biogen

Charles Davies, associate vice president, Global Sourcing & Procurement, Merck & Co.

Sally Macaluso, Vice president, Johnson & Johnson Marketing and Business Services Procurement, Johnson & Johnson

Steve Poland, global director, 3rd Party FDF Technical Support, Mylan

Sami Yusuf, vice president, Corporate Development, Upsher-Smith

Past Presidents:

Immediate Past President: Joe Sutton, Global Director, Sourcing, Eli Lilly

2nd Immediate Past President: Milton Boyer, CEO, SCA Pharmaceuticals

Register now!

The latest information directly via newsletter.

To prevent automated spam submissions leave this field empty.